Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03418480
What this trial is testing

HARE-40: HPV Anti-CD40 RNA vaccinE

Who this might be right for
Human Papilloma Virus Related CarcinomaHead and Neck NeoplasmCervical Neoplasm+2 more
University of Southampton 32
Not applicableWithdrawnNCT01551537
What this trial is testing

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Large-scale testing (Phase 3)WithdrawnNCT02082639
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Post-approval studies (Phase 4)Study completedNCT01031069
What this trial is testing

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 873
Not applicableEnded earlyNCT01355003
What this trial is testing

GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT01461096
What this trial is testing

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 575
Large-scale testing (Phase 3)Study completedNCT01190189
What this trial is testing

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 137
Large-scale testing (Phase 3)Study completedNCT00337428
What this trial is testing

Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 843
Large-scale testing (Phase 3)Study completedNCT02979535
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 480
Large-scale testing (Phase 3)UnknownNCT05580341
What this trial is testing

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Who this might be right for
Cervical CancerGenital WartCIN+2 more
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Large-scale testing (Phase 3)Study completedNCT01249365
What this trial is testing

The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 199
Early research (Phase 1)UnknownNCT05672966
What this trial is testing

Phase I Clinical Trial of a Candidate HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Wuhan BravoVax Co., Ltd. 40
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Large-scale testing (Phase 3)UnknownNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00344032
What this trial is testing

Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 354
Large-scale testing (Phase 3)Study completedNCT01190176
What this trial is testing

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 34
Large-scale testing (Phase 3)Looking for participantsNCT05625633
What this trial is testing

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Who this might be right for
Warts
Western Institute for Veterans Research 120
Next Page